Back to Journals » Hepatic Medicine: Evidence and Research » Volume 12 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/61/cope/thumb_100_1000_100.jpg)
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (190)
- Volume 16, 2024 (5)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 12, 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Chemical Risk Factors of Primary Liver Cancer: An Update
Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A
Hepatic Medicine: Evidence and Research 2020, 12:179-188
Published Date: 5 January 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
Tafere GG, Wondafrash DZ, Demoz FB
Hepatic Medicine: Evidence and Research 2020, 12:173-178
Published Date: 3 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature
Zaccherini G, Tufoni M, Bernardi M
Hepatic Medicine: Evidence and Research 2020, 12:153-172
Published Date: 27 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
Teshome G, Ambachew S, Fasil A, Abebe M
Hepatic Medicine: Evidence and Research 2020, 12:139-151
Published Date: 24 September 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Identifying High-Risk NASH Patients: What We Know so Far
Schulz M, Tacke F
Hepatic Medicine: Evidence and Research 2020, 12:125-138
Published Date: 21 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
Diaz Soto MP, Lim JK
Hepatic Medicine: Evidence and Research 2020, 12:115-123
Published Date: 13 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils
Khuntikeo N, Titapun A, Chamadol N, Boonphongsathien W, Sa-Ngiamwibool P, Taylor-Robinson SD, Wadsworth CA, Zhang S, Kardoulaki EM, Syms RRA
Hepatic Medicine: Evidence and Research 2020, 12:107-114
Published Date: 27 July 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet
Elshaghabee FMF, Ghadimi D, Habermann D, de Vrese M, Bockelmann W, Kaatsch HJ, Heller KJ, Schrezenmeir J
Hepatic Medicine: Evidence and Research 2020, 12:93-106
Published Date: 26 June 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
In vitro Differentiation of Human TERT-Transfected Multi-Lineage Progenitor Cells (MLPC) into Immortalized Hepatocyte-Like Cells
Collins DP, Hapke JH, Aravalli RN, Steer CJ
Hepatic Medicine: Evidence and Research 2020, 12:79-92
Published Date: 11 June 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on Emerging Treatment Options for Primary Biliary Cholangitis
Aguilar MT, Chascsa DM
Hepatic Medicine: Evidence and Research 2020, 12:69-77
Published Date: 25 May 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
Zhdanov K, Isakov V, Burnevich E, Kizhlo S, Bakulin I, Pokrovsky V, Liang L, Hwang P, Talwani R, Haber BA, Robertson MN
Hepatic Medicine: Evidence and Research 2020, 12:61-68
Published Date: 21 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Clinical Implications of Thrombocytopenia for the Cirrhotic Patient
Sigal SH, Sherman Z, Jesudian A
Hepatic Medicine: Evidence and Research 2020, 12:49-60
Published Date: 14 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
Serra JT, Mueller J, Teng H, Elshaarawy O, Mueller S
Hepatic Medicine: Evidence and Research 2020, 12:41-48
Published Date: 27 March 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Improving the Detection of Cholangiocarcinoma: In vitro MRI-Based Study Using Local Coils and T2 Mapping
Khuntikeo N, Titapun A, Chamadol N, Boonphongsathien W, Sa-Ngiamwibool P, Taylor-Robinson SD, Wadsworth CA, Zhang S, Kardoulaki EM, Young IR, Syms RRA
Hepatic Medicine: Evidence and Research 2020, 12:29-39
Published Date: 24 March 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells
Aravalli RN, Collins DP, Hapke JH, Crane AT, Steer CJ
Hepatic Medicine: Evidence and Research 2020, 12:15-27
Published Date: 13 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions
Mehrotra S, Lalwani S, Nundy S
Hepatic Medicine: Evidence and Research 2020, 12:1-13
Published Date: 23 January 2020